...
首页> 外文期刊>Naunyn-Schmiedeberg's Archives of Pharmacology >Contrasting effects of streptozotocin-induced diabetes on the in vitro relaxant properties of adenosine in rat pancreatic vascular bed and thoracic aorta.
【24h】

Contrasting effects of streptozotocin-induced diabetes on the in vitro relaxant properties of adenosine in rat pancreatic vascular bed and thoracic aorta.

机译:链脲佐菌素诱发的糖尿病对大鼠胰血管床和胸主动脉中腺苷的体外松弛特性的对比作用。

获取原文
获取原文并翻译 | 示例
           

摘要

In the present work, we have studied adenosine-induced vasodilation in streptozotocin-induced diabetic rats and compared it to that observed in normal age-matched or weight-matched animals. Experiments were performed on a vascular bed, the isolated perfused pancreas, and a large vessel, the thoracic aorta, provided from the same animal. Vasodilator activity was assessed, for isolated pancreas, as the increase in flow induced by the infusion of 2 microM adenosine for 30 min, or for noradrenaline-contracted aortae, as the relaxant response to adenosine (1 microM-1 mM). In both preparations the results obtained with selective adenosine receptors ligands (CPA, CGS 21680 and NECA) agreed with the presence of adenosine receptor of A2a subtype. In normal animals, adenosine vasodilator activity on both preparations diminished with advancing age in the rat, while diabetes was associated with a decreased or increased responsiveness to adenosine in pancreatic vascular bed or aorta, respectively. Further, the involvement of nitric oxide (NO), in relaxant responses, was evaluated by the use of the NO synthase inhibitor Nomega-nitro-L-arginine methyl ester (L-NAME). In all groups of animals, the flow rate of isolated pancreas dropped in the presence of 200 microM L-NAME, but was restored by adenosine to the level observed without L-NAME. L-NAME (10 microM) significantly reduced the dilator response to adenosine in aortic rings from diabetic animals, but not in those from normal rats. These results showed that adenosine vasorelaxant activity is significantly but differentially altered by diabetes according to the origin of the vascular preparation, and suggest that NO is involved in the vasorelaxant activity of adenosine in large vessels of diabetic animals. The potential pathophysiological role of adenosine in the vascular complications of diabetes remains to be determined.
机译:在目前的工作中,我们研究了在链脲佐菌素诱导的糖尿病大鼠中腺苷诱导的血管舒张,并将其与正常年龄匹配或体重匹配的动物中观察到的进行了比较。实验是在由同一只动物提供的血管床,分离的灌注胰腺和大血管胸主动脉上进行的。对于离体的胰腺,评估血管扩张剂的活性,方法是注入2 microM腺苷30分钟诱导增加的流量,或评估去甲肾上腺素收缩的主动脉对腺苷的松弛反应(1 microM-1 mM)。在两种制剂中,用选择性腺苷受体配体(CPA,CGS 21680和NECA)获得的结果均与A2a亚型腺苷受体的存在一致。在正常动物中,两种制剂的腺苷血管扩张剂活性随大鼠年龄的增长而降低,而糖尿病分别与胰腺血管床或主动脉中对腺苷的响应性降低或升高有关。此外,通过使用NO合酶抑制剂Nomega-硝基-L-精氨酸甲酯(L-NAME)评估了一氧化氮(NO)参与松弛反应。在所有动物组中,在存在200 microM L-NAME的情况下,分离的胰腺的流速下降,但是腺苷将其恢复至没有L-NAME的水平。 L-NAME(10 microM)在糖尿病动物的主动脉环中显着降低了扩张剂对腺苷的反应,但在正常大鼠中却没有。这些结果表明,根据血管制剂的来源,腺苷的血管舒张活性显着但有差异地改变,并且表明NO参与糖尿病动物大血管中腺苷的血管舒张活性。腺苷在糖尿病血管并发症中的潜在病理生理作用尚待确定。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号